Panbela provides business update and reports q2 2024 financial results

Minneapolis, aug. 13, 2024 (globe newswire) -- panbela therapeutics, inc. (otcqb: pbla), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended june 30, 2024. as previously announced, management is hosting an earnings call today at 4:30 p.m. et.
PBLA Ratings Summary
PBLA Quant Ranking